Radius Health - RDUS Quarterly EPS earnings growth

Radius Pharmaceuticals - graphic logo of issuer RDUS

Radius Recycling, Inc. (RDUS) provides the industry with secondary resources for decarbonization and is currently in a maturity phase. Revenues are based on the sale of bone-strengthening medications to patients with osteoporosis. High barriers to entry are created by patents and strict FDA oversight. The GURU.Markets website contains the quarter-over-quarter EPS dynamics, where 91.60 expresses the latest level of the metric.

Radius Recycling (RDUS) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 07/26/2025

Financial and market metric breakdowns for Radius Recycling, Inc. (RDUS)

- share price and consensus valuation forecast:
Analysis of all company metrics:Radius Recycling, Inc.
Manufactured product of Radius Pharmaceuticals

Radius Recycling, Inc. (RDUS) focuses on the commercialization of innovative oncology and osteoporosis therapies, which requires significant R&D investment. By analyzing the quarterly EPS growth rate, recorded at 91.60, an investor assesses the pace of change in net income per share relative to the previous period, identifying the impact of operating expenses and wage pressures on the business's bottom-line profitability.

Competitors of Radius Recycling, Inc. (RDUS)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept Therapeutics Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Pharmaceuticals|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (Metsera, Inc.)|Year-over-year earnings per share growth for the last twelve months moonlaketx.com MLTX|Crinetics Corp (CRNX) - Earnings per share growth in annualized terms for the last twelve months|NAMS - Year-over-year earnings per share growth for the last twelve months|SLNO: Year-over-year earnings per share growth for the last twelve months|FOLD: Quarterly EPS earnings growth|ETNB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agios Corp|Structure Corp (GPCR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months mimedx.com (MDXG)|Year-over-year net earnings per share growth for the last 12 months rezolutebio.com RZLT|Year-over-year earnings per share growth for the last twelve months Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Year-over-year earnings per share growth for the last twelve months|ALT: Year-over-year net earnings per share growth for the last 12 months|AARD - Quarterly EPS earnings growth|SGMT: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months BioAge Labs, Inc. (BIOA)|Year-over-year earnings per share growth for the last twelve months Biomea Fusion Inc|Year-over-year earnings per share growth for the last 12 months QNCX (Quince Therapeutics)|Year-over-year net earnings per share growth for the last 12 months GUTS (Fractyl Health)|Year-over-year earnings per share growth rate for the last twelve months VTVT|Agape ATP Corporation - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PLUR|Synlogic Inc. - Quarterly EPS earnings growth|LPCN (Lipocine) - Year-over-year earnings per share growth for the last 12 months|MTNB (Matinas BioPharma Holdings Inc.) - Year-over-year net earnings per share growth for the last 12 months|SPRB (Spruce Biosciences, Inc.) - Year-over-year earnings per share growth for the last twelve months|GLTO (galecto.com) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months carmellrx.com (CTCX)|Year-over-year earnings per share growth for the last twelve months Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Year-over-year earnings per one share growth for the last 12 months